Stock buybacks aren't bad. They aren't good, either.
"We don't see massive misuse as some people allege. This isn't a rigged game where CEOs are lining their pockets."
"We don't see massive misuse as some people allege. This isn't a rigged game where CEOs are lining their pockets."
The thesis of Prof. David Thesmar's study is that IICCs, not Capm outputs, are the right discount rates to use in each category of company.
Prof. Michelle Hanlon urges caution in determining AFSI for insurers.
"If you combine multiple diseases into a single financial portfolio, all of a sudden the risk-reward trade off becomes more attractive."
Prof. Stuart Madnick says federal law doesn't require companies to report ransomware payments beyond those affecting critical infrastructure.
WSJ Wealth Expert Antoinette Schoar of MIT discusses her research on the quality of financial advice commonly given to clients.
Senior Mercy Oladipo is building tools to address disparities in health care.
"The risk is that companies will use blockchain methods to record transactions without even caring whether the information ... is true."
"Diversifying the source of ESG ratings is very helpful. Having more than one source ... [helps] you get rid of some noise."
"We are here as two women working in tech and finance to call for a serious examination of the financing needs of today's innovators."